J&J hikes 2021 profit forecast, COVID-19 vaccine sales grow

10/19/2021 | by | Uncategorized

Johnson & Johnson is raising its 2021 profit forecast again after growing sales of the cancer treatment Darzalex and other drugs pushed it past Wall Street’s third-quarter earnings expectations
Source: Test feed

Leave a Comment

Your email address will not be published.

*
*
*